KM Financial Solutions | Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ
56318
post-template-default,single,single-post,postid-56318,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ

Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ

Swiss drugmaker Novartis AG is
nearing an agreement to acquire U.S. biotechnology firm The
Medicines Co for about $7 billion, the Wall Street
Journal reported https://on.wsj.com/2qveZtj on Saturday.

No Comments

Sorry, the comment form is closed at this time.